Preparation and properties of lipotropin C-Fragment with anionic substituents attached to the lysine residues  by Geisow, M.J. & Smyth, D.G.
Volume 8 1, number 2 FEBS LETTERS September 1977 
PREPARATION AND PROPERTIES OF LIPOTROPIN C-FRAGMENT WITH ANIONIC 
SUBSTITUENTS ATTACHED TO THE LYSINE RESIDUES 
M. J. GEISOW and D. G. SMYTH 
National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 IAA, England 
Received 21 July 1977 
1. Introduction 
C-Fragment was first isolated from porcine pitu- 
itary glands and shown to comprise residues 61-9 1 of 
lipotropin [l] . The 3 1 -residue peptide acts as a 
potent opiate agonist in the central nervous system; 
it binds specifically to morphine receptors in brain 
[2] and produces long-lasting analgesia when adminis- 
tered cerebroventricularly [3,4]. It seems certain that 
the NHz-terminal pentapeptide of C-Fragment forms 
a binding site which is necessary for the expression of 
opiate activity [2]. Although this section is present in 
a number of peptides derived from C-Fragment 
(methionine enkephalin, 6 l-65 ; yendorphin, 6 i -77, 
and C’-Fragment ,6 l-87) these molecules are compa- 
ratively weak agonists. A question thus arises concern- 
ing the role of the COOH-terminal residues of C-Frag- 
ment. One possibility is that these residues form 
direct binding interactions with brain opiate receptors; 
another is that they might induce a specific conforma- 
tion of the NH*-terminal region of the molecule by 
an intramolecular effect. It is anticipated that studies 
with synthetic or chemically modified derivatives of 
C-Fragment should clarify the function of the COOH- 
terminal region. 
A characteristic feature of the C-Fragment sequence 
is its high content of lysine residues. Of these, the 
paired residues in the COOH-terminal tetrapeptide 
appear to be important for the agonist activity since 
their absence from C-Fragment, as in C’-Fragment, 
leads to severe loss of analgesic potency [S] . In order 
to investigate the role of the lysine residues, modifica- 
tion of the e-NH* groups was undertaken by a route 
which did not involve reaction at the essential NH2- 
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group of the terminal tyrosine. This was achieved by 
trypsin digestion of citraconylated lipotropin, which 
allowed the isolation of e-N-pentacitraconyl C-Frag- 
ment (CT5 C-Fragment) together with arginine- 
containing peptides derived from the NH2-terminal 
region of lipotropin. 
A preparation of C-Fragment from ovine lipo- 
tropin has been described which involved the forma- 
tion of the citraconylated peptide as an intermediate 
[6] but the product was not isolated. In this report 
we describe the preparation of CT5 C-Fragment in 
homogeneous form and in high yield; a study of its 
binding properties to brain opiate receptors is 
presented. 
2. Materials and methods 
2.1. Preparation of citraconylated lipotropin 
Lipotropin (1.3 gmol), obtained from porcine 
pituitary [l] , was dissolved in 2 ml 0.5 M Na2HP04, 
at pH 8.5 and a 300-ftild molar excess of citraconic 
anhydride (Aldrich) as a 30% v/v solution in 1,4 
dioxan was added with vigorous mixing. At intervals 
during the addition the pH of the reaction mixture 
was adjusted to 8.5 with 1 M NaOH and the solution 
was incubated for 1 h. Complete substitution of amino 
groups was demonstrated by dansylation of 1 nmol 
peptide, with glycine added as an internal standard; 
after hydrolysis no e-N-dansyllysine or dansylglutamic 
acid could be detected. 
2.2. Tryptic digestion of citraconylated lipotropin 
Digestion was performed with TPCK-treated 
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Fig.1. Gel filtration of tryptic peptides derived from citra- 
conylated lipotropin (CT,, Iipotropin) on Sephadex G-50 in 
0.02 M Tris--HCl, pH 8.5. Fraction volumes were 4.0 ml. 
trypsin (Worthington) at an enzyme/peptide ratio 
of 1:400, w/w, at pH 8.5 and 37”C, using the same 
solution employed in the citraconylation reaction. 
After 2 h the digestion was terminated by the addition 
of a four-fold molar excess of ovomucoid trypsin 
inhibitor (Sigma), which was allowed to react for 
5 min at 37°C. 
2.3. Chromatography of the tryptic peptides 
The digestion mixture was applied to a 122 X 1.5 
cm column of Sephadex G-50 equilibrated with 0.02 M 
Tris-HCI, at pH 8.5. The first fraction contained 
three peptides, accounting for residues I-23, 24-51 
and 61-91 of lipotropin; the digestion conditions did 
not lead to cleavage of the Arg-Asp bond in peptide 
l-23. The second fraction contained the nonapeptide 
52-60 and citraconic acid. The combined fractions 
from the first peak were applied to a 40 X 0.9 cm 
column of DEAE-Sephadex A 25 equilibrated with 
0.02 M Tris-HCl, at pH 8.5. Peptides were eluted 
with a linear salt gradient formed from 200 ml 0.1 M 
NaCl and 200 ml OS M NaCl in the equilibration 
buffer (fig.2). 
The compositions and yields of the peptides 
obtained are listed in table 1. Single fraction amino 
acid analysis of material in the shoulder on the 
CTs-C-Fragment peak was identical in composition 
to the main peak. As this retarded material is more 
acidic, it seems likely to contain citraconylated 
serine and threonine residues, a side reaction known 
to be involved in the citraconylation of proteins [7]. 
This material was not present in the peptide solutions 
used in the binding studies. The peptides l-23 and 
24-5 I, which contain no serine and threonine, were 
eluted in symmetrical peaks. 
2.4. Removal of the citraconyl groups 
Peptides were incubated in 0.1 M pyridine-acetate, 
at pH 4, for 24 h, 37°C and the solutions were con- 
centrated in vacua. The peptides were desalted on 
columns of Sephadex G-25 in 50% (v/v) acetic acid 
and the solvent was removed by rotary evaporation 
at below 25°C. The 61-91 peptide thus obtained 
had an absorption spectrum and composition indis- 
tinguishable from that of C-Fragment isolated from 
pituitary. 
I 1-23 61-91 24-51 
1.0 
i ,I 
.a - 
s: 
,” .6- _\
.4 - 
t 
~-1 , 
20 40 60 80 100 
FRACTION No. 
Fig.2. Elution profile of tryptic peptides from CT,, lipotropin 
from DEAE-Sephadex A 25. Fraction volumes were 4.5 ml. 
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Table 1 
Composition of tryptic peptides obtained from citraconylated lipotropin 
Peptide l-23 61-91 24-51 
(residue number) 
Yield (Mmol) 1.01 1.02 0.8 
Recovery (%) 79 80 63 
Composition Obs. Theor. Obs. Theor. Obs. Theor. 
Lys 0.0 0 5.0 5 3.0 3 
His 0.0 0 1.0 1 1.0 1 
Arg 1.9 2 0.0 0 1.0 1 
Asp 0.9 1 2.0 2 1.0 1 
Thr 0.0 0 2.8 3 0.0 0 
Ser 0.0 0 1.9 2 0.0 0 
Glu 4.0 4 3.0 3 7.2 7 
Pro 5.3 5 1.0 1 1.0 1 
GlY 2.2 2 3.0 3 1.8 2 
Ala 8.4 8 1.95 2 4.6 5 
Val 0.0 0 1.4a 2 1.0 1 
Met 0.0 0 0.8 1 0.94 1 
He 0.0 0 0.4a 1 0.0 0 
Leu 1.1 1 2.4 2 2.0 2 
Tyr 0.0 0 0.8 1 1.6 2 
Phe 0.0 0 1.8 2 0.92 1 
a Resistant Be-Val bond 
Analysis was carried out after 16 h hydrolysis in 6 N HCl at 110°C 
2.5. Measurement of the affinity of CT, C-Fragment 
for brain opiate receptors 
The ability of peptides to reduce the specific 
binding of [G3H]naloxone (New England Nuclear, 
20 Ci; mmol-‘, 1 X 10d9 M) and [l ,7,8-3H]dihydro- 
morphine (Radiochemical Centre, Amersham, 70 Ci; 
mmol-' , 1 X %10e9 M) was measured essentially as 
previously described [2]. Incubation of tritiated 
opiates, peptides and membranes was carried out for 
15 min at 30°C in 1 ml 0.05 M Tris-HCl, pH 7.4, 
containing 100 mM NaCl. 
3. Results and discussion 
The ability of CT5 C-Fragment to reduce the 
specific binding of [3H]naloxone and [3H] dihydro- 
morphine to brain membranes was compared with that 
of C-Fragment (fig.3). The binding curves show that 
modification of the five lysine residues leads to a 
large decrease in affinity. The product was three orders 
of magnitude less effective than C-Fragment in dis- 
Loglo[Peptide] 
Fig.3. The curves show the displacement of specifically- 
bound opiates from rat brain synaptosomal membranes. I,, 
is the peptide concentration required for 50% displacement 
of specifically-bound opiate. (-•-a-) Displacement of [G3H] 
naloxone by acid-treated CT, C-Fragment, I,, 3 nM; (o-o) 
Displacement of [ 1,7,8-‘Hldihydromorphine by CT, C-Frag- 
ment, Is,, 0.7 pM; (m-m) Displacement of [G-“Hlnaloxone 
by CT, C-Fragment, I,, 4.0 PM. 
433 
Volume 8 1, number 2 FEBS LETTERS September 1977 
placing naloxone from the brain receptors. It was 
forty-times less potent than the pentapeptide methio- 
nine enkephalin in the same assay. Removal of the 
substituents led to full recovery of the C-Fragment 
potency, assessed by binding and by analgesic activity. 
It should be noted that the NH2-terminal octa- 
peptide of C-Fragment (61-68) which does not 
contain a lysine residue, is not affected by the citra- 
conylation reaction. The decrease in the binding 
properties of C-Fragment accompanying citraconyla- 
tion must therefore be the consequence of the 
modification of residues which are distant from the 
NH*-terminus. The low affinity cannot be due to 
rapid degradation of the peptide during the binding 
assay since the pentacitraconyl derivative exhibited 
the same high resistance as C-Fragment to the action 
of brain exopeptidases [8] ; nor does it seem likely 
that the low affinity should be due to a disturbance 
of conformation in the NHz-terminal region because 
C-Fragment, which lacks the lysine residues at posi- 
tions 88 and 89, has conformational properties similar 
to those of C-Fragment. These properties protect the 
NH,-terminus from proteolytic attack, a phenom- 
enon exhibited by C-Fragment, C-Fragment and 
CT5 C-Fragment [8]. 
The low affinity of the CT5 C-Fragment for brain 
opiate receptors may be attributed to the inversion of 
charge on the lysine residues. It seems likely that receptors 
possess anionic groups proximal to the e-NH3 groups 
of C-Fragment; the anionic nature of CT5 C-Fragment 
would tend to exclude this derivative from the 
receptor site. The same effect could result if the sub- 
stituents interfered sterically with the formation of 
the peptide-receptor complex. In either case the 
results emphasise the importance of the region of the 
peptide chain contiguous with the NHz-terminal 
pentapeptide for receptor affinity. In particular the 
basic residues must be considered as candidates for 
receptor interaction. Further experiments involving 
modification of individual lysine residues will clarify 
their molecular role in the central activity of C-Fragm- 
ent. 
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